Skip to product information
1 of 1

ABCbiolab

SKU:ABCC25793

ELISA Kit for Lemur Tyrosine Kinase 3 (LMTK3)

ELISA Kit for Lemur Tyrosine Kinase 3 (LMTK3)

Regular price $700.00 USD
Regular price Sale price $700.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Sensitivity
Host

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

0.156-10ng/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Homo sapiens (Human)

Sensitivity

The minimum detectable dose of this kit is typically less than 0.058ng/mL

Sample type

tissue homogenates, cell lysates and other biological fluids

Assay length

3h

Method

Double-antibody Sandwich

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Lemur Tyrosine Kinase 3 (LMTK3). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Lemur Tyrosine Kinase 3 (LMTK3). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Lemur Tyrosine Kinase 3 (LMTK3), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Lemur Tyrosine Kinase 3 (LMTK3) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Alternative Names

LMR3; TYKLM3; Serine/threonine-protein kinase LMTK3

Item Name

Lemur Tyrosine Kinase 3

Research Area

Enzyme & Kinase;

Reference

Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis;Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression;

View full details